Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47K Buy
+9
New +$1.38K ﹤0.01% 1733
2025
Q2
Sell
-70
Closed -$5.34K 1148
2025
Q1
$5.34K Buy
+70
New +$5.36K ﹤0.01% 1394
2024
Q3
Sell
-100
Closed -$2.71K 1941
2024
Q2
$2.71K Hold
100
﹤0.01% 1804
2024
Q1
$3.1K Buy
+100
New +$2.8K ﹤0.01% 1453

Other funds holding INSM

Mather Group's INSM Position: Q1 2026 in Review

Mather Group opened a new position in Insmed (INSM) in Q1 2026: 9 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #1733 among its holdings. This is a return to the name: Mather Group previously reported a position in INSM as recently as Q1 2025.

Mather Group first reported a position in INSM in Q1 2024 and has held it in 4 quarters since. The position peaked at $5.34K in Q1 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Mather Group held 9 shares of Insmed worth $1.47K as of Q1 2026.
  • Insmed was a new Mather Group position in Q1 2026.
  • Insmed made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #1733 holding.
  • Mather Group first reported a position in Insmed in Q1 2024 and has held it in 4 quarters since.
  • Mather Group's Insmed position peaked at $5.34K in Q1 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.